In the last few weeks, the FDA has started to limit COVID vaccine approvals, limiting their use in healthy people under 65 ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

Lakshmi Panagiotakopoulos said she could no longer help vulnerable people after officials removed recommendations to immunize ...

For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.

Dr. Marty Makary, the Johns Hopkins surgeon and professor who, Trump tapped to lead the FDA, clarified the recently changed ...

Pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos of the U.S. CDC resigned on Tuesday as co-leader of a ...

The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around ...

Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.

Leaders from the US Food and Drug Administration outlined a new framework for the approval process for Covid-19 vaccines that ...